HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

NOV 002

a 1000-to-1 mixture of glutathione disulfide and cisplatin that is used to increase efficacy of chemotherapy against advanced non-small cell lung cancer; modulates cellular redox balance
Also Known As:
NOV-002; NOV002
Networked: 5 relevant articles (3 outcomes, 2 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Pazoles, Christopher J: 3 articles (05/2012 - 04/2008)
2. Tew, Kenneth D: 3 articles (01/2010 - 04/2008)
3. Townsend, Danyelle M: 3 articles (01/2010 - 04/2008)
4. Montero, Alberto J: 1 article (05/2012)
5. Feng, Wei: 1 article (05/2012)
6. Zidan, Abdel-Aziz: 1 article (05/2012)
7. Zhou, Daohong: 1 article (05/2012)
8. Diaz-Montero, C Marcela: 1 article (05/2012)
9. Shao, Lijian: 1 article (05/2012)
10. Wang, Yong: 1 article (05/2012)

Related Diseases

1. Neoplasms (Cancer)
2. Ovarian Neoplasms (Ovarian Cancer)
3. Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
4. Breast Neoplasms (Breast Cancer)
5. Neoplasm Metastasis (Metastasis)

Related Drugs and Biologics

1. Cisplatin (Platino)
2. Glutathione Disulfide (GSSG)
3. Doxorubicin (Adriamycin)
4. Cyclophosphamide (Cytoxan)
5. docetaxel (Taxotere)

Related Therapies and Procedures

1. Drug Therapy (Chemotherapy)
2. Neoadjuvant Therapy
3. Injections